A prospective study evaluating the relationship between preoperative serum UST levels and 30-day postoperative outcomes among CD and UC patients undergoing abdominal surgery
Latest Information Update: 06 Jul 2021
At a glance
- Drugs Ustekinumab (Primary)
- Indications Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis
- Focus Pharmacodynamics
- 06 Jul 2021 New trial record
- 23 May 2021 Results presented at the Digestive Disease Week 2021